[6/29 held webinar] Introducing new functions of drug discovery support AI "Cascade Eye" that visualizes and structures relationships between complex genes and molecules
In the drug discovery process, searching for a target requires work such as "searching for a needle in hay" to search for limited information from a huge amount of paper data.However, it is difficult to perform comprehensive analysis by searching for information by humans, which has become a major issue in recent years.
In this webinar, FRONTEO's drug discovery support AI program that can visualize and structure information on molecules and genes related to the disease to be analyzed in the form of a pathway map (route map showing the relationship) based on a huge amount of paper information. Introducing "Cascade Eye" including new features. Cascade Eye is an AI program that visualizes the relationships between genes and molecules, and is useful for discovering new action mechanisms and indications that are difficult to notice when searching for articles.
In addition, the research team will also demonstrate the product in this webinar, so you can imagine the function more concretely.
◆ Theme: Introducing new functions of drug discovery support AI "Cascade Eye" that visualizes and structures the relationships between complex genes and molecules
◆ Date: May 2022, 6 (Wednesday) 29: 12-10: 12
・ Those who think that the drug discovery process will be streamlined with AI
・ Those involved in drug discovery research
◆ Participation conditions: Those who use free addresses, those who are in the same industry as our company, and those whose affiliation is unknown are not allowed to apply.When accessing ZOOM on the day of the event, please enter the name and email address you provided when you applied for the ZOOM participation input field.
Yukari Oda
After serving as a manager in the food industry, such as store management, he entered the healthcare industry.He is involved in drug and infusion sales at multiple pharmaceutical companies.He has experienced a wide range of disease areas such as cardiovascular, respiratory, skin and metabolic endocrine areas. She joined FRONTEO and proposes AI solutions mainly to pharmaceutical companies.
Articles in the same category
Exploring patient stratification biomarkers for IgA nephropathy using AI: Overcoming bias with AI
Parkinson's disease - Analyzing drug discovery targets using paper search AI
Economic Security Symposium co-hosted by FRONTEO x Moody's Analytics Japan on April 4th
Searching for new targets for sporadic ALS using AI: Become friends with AI
[Webinar held on 3/25] Risk of important information leakage of Japanese companies due to cross-border application of discovery and its response
[On-site seminar held on 3/19] Latest trends in AI and competition law - from a global perspective <Simultaneous interpretation and reception available>
[Webinar held on 3/5] Are you fully prepared for a series of information leaks?: Recommendation of mock training from a crisis management perspective
[3/13 31st Economic Security Study Session] Strategic importance of “India” towards the post-China era
[Webinar held on 3/12] Learning from court precedents: “Initial response and legal measures in cases of trade secrets taken out by retired employees”